A phase II study of the PARP inhibitor ABT-888 plus temozolomide in patients with heavily pretreated, metastatic colorectal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.3502 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 3502-3502 ◽

Author(s):

M. J. Pishvaian ◽

R. Slack ◽

A. Witkiewicz ◽

A. R. He ◽

J. J. Hwang ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Parp Inhibitor ◽

Heavily Pretreated

Download Full-text

A Phase II Study of Cetuximab/Irinotecan in Patients with Heavily Pretreated Metastatic Colorectal Cancer: Predictive Value of Early Specific Toxicities

Clinical Colorectal Cancer ◽

10.3816/ccc.2008.n.035 ◽

2008 ◽

Vol 7 (4) ◽

pp. 273-279 ◽

Author(s):

Teresa Gamucci ◽

Fabrizio Nelli ◽

Giovanni Cianci ◽

Giulia Grassi ◽

Luca Moscetti ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Predictive Value ◽

Phase Ii Study ◽

Heavily Pretreated

Download Full-text

A Single Center Phase II Study of Continuous Infusion of Low-dose 5- fluorouracil for Heavily Pretreated Patients With Metastatic Colorectal Cancer

Clinical Cancer Drugs ◽

10.2174/2212697x02666151026215656 ◽

2015 ◽

Vol 2 (2) ◽

pp. 87-90

Author(s):

Hong-tao Chen ◽

Yi-feng Liao ◽

Mei Xiao ◽

Lin Ma ◽

Hong-Yu Zhang

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Single Center ◽

Heavily Pretreated ◽

Pretreated Patients

Download Full-text

A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.13511 ◽

2021 ◽

Author(s):

Mingzhu Huang ◽

Yue Yang ◽

Xiaodong Zhu ◽

Zhiyu Chen ◽

Wen Zhang ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Salvage Treatment ◽

Prospective Phase

Download Full-text

Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(88)90321-5 ◽

1988 ◽

Vol 24 (4) ◽

pp. 801-802 ◽

Author(s):

Janke Greidanus ◽

Pax H.B. Willemse ◽

Dirk Th. Sleijfer ◽

Nanno H. Mulder ◽

RenéC.J. Verschueren ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Phase Ii Study ◽

Infusion Schedule

Download Full-text

Phase II Study of Recombinant Antitumor and Antivirus Protein Injection Compared With Placebo in Metastatic Colorectal Cancer After Failure of Standard Treatment

The Oncologist ◽

10.1634/theoncologist.2014-0439 ◽

2015 ◽

Vol 20 (6) ◽

pp. 619-620

Author(s):

Ru Jia ◽

Yan Wang ◽

Xiao‐Yang Mao ◽

Shan‐Shan Li ◽

Nong Xu ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Standard Treatment ◽

Download Full-text

A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e31826b9c94 ◽

2014 ◽

Vol 37 (1) ◽

pp. 19-23 ◽

Author(s):

Yong Sang Hong ◽

Sung Sook Lee ◽

Kyu-pyo Kim ◽

Jae-Lyun Lee ◽

Yoon-Koo Kang ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Download Full-text

270 A phase II study of oral uracil/ftorafu (UFT) plus leucovorin in combination with mitomycin-C in patients with metastatic colorectal cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90303-x ◽

2003 ◽

Vol 1 (5) ◽

pp. S83

Author(s):

N. Glydenkerne ◽

B. Glimelius ◽

J.-E. Frödin ◽

M. Kjaer ◽

P. Pfeiffer ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Mitomycin C ◽

Phase Ii ◽

Download Full-text

Relationship between high dose irinotecan (260mg/m2) and response rate, without increased toxicities in metastatic colorectal cancer (MCRC) combination with bi-weekly 5FU/FA in a phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(01)81587-2 ◽

2001 ◽

Vol 37 ◽

pp. S297 ◽

Author(s):

M. Ducreux ◽

J. Raoul ◽

Y. Merrouche ◽

P. Marti ◽

M. Risse ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Response Rate ◽

Phase Ii Study ◽

Download Full-text

Updated report: A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402)

Annals of Oncology ◽

10.1093/annonc/mdw370.95 ◽

2016 ◽

Vol 27 ◽

pp. vi180

Author(s):

S. Yuki ◽

Y. Komatsu ◽

H. Satake ◽

Y. Miyamoto ◽

H. Tanioka ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Phase II Study of Irinotecan, Leucovorin, 5-Fluorouracil and Tegafur/Uracil for Metastatic Colorectal Cancer

Journal of Chemotherapy ◽

10.1179/joc.2005.17.2.224 ◽

2005 ◽

Vol 17 (2) ◽

pp. 224-227 ◽

Author(s):

T. Kono ◽

Y. Ebisawa ◽

I. Tomita ◽

N. Chisato ◽

K. Kamiya ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Download Full-text